EP2854769
AÐFERÐIR VIÐ AÐ MEÐHÖNDLA LIÐAGIGT
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.7.2013EP published:
7.6.2023EP application number:
13813286.5
EP translation filed:
4.7.2023Grant published:
15.8.2023EPO information:
European Patent Register
Max expiry date:
4.7.2033Expiry date:
4.7.2026Next due date:
31.7.2026
Title in English:
METHODS OF TREATING ARTHRITISLanguage of the patent:
English
Timeline
Today
5.7.2013EP application
7.6.2023EP Publication
4.7.2023Translation submitted
15.8.2023Registration published
4.7.2026Expires
Owner
Name:
Taiwan Liposome Company, Ltd.Address:
11F-1 No 3 Yuanqu Street Nangang District, Taipei City 11503, TW
Name:
TLC Biopharmaceuticals, Inc.Address:
611 Gateway Blvd., Suite 830, South San Francisco CA 94080, US
Inventor
Name:
HONG, KeelungAddress:
South San Francisco, California 94080, US
Name:
GUO, Luke S.S.Address:
South San Francisco, California 94080, US
Name:
TSENG, Yun-LongAddress:
Taipei City 11503, TW
Name:
SHIH, Sheue-FangAddress:
Taipei City 11503, TW
Name:
CHANG, Po-ChunAddress:
Taipei City 11503, TW
Name:
TSAI, Chih-ChiangAddress:
Taipei City 11503, TW
Name:
LIN, Hong-HuiAddress:
Taipei City 11503, TW
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201261668446 PDate:
5.7.2012Country:
US
Number:
201361791650 PDate:
15.3.2013Country:
US
Classification
Categories:
A61K 9/127, A61K 9/19, A61K 9/00, A61K 38/17, A61K 31/405, A61K 31/519, A61K 31/573, A61P 19/02, A61P 29/00
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 29.9.2023
Expires: 4.7.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 7.6.2024
Expires: 4.7.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 4.7.2025
Expires: 4.7.2026
Payer: Árnason Faktor ehf.